PD2-2 The Role of Molecular Targeting Therapy for Metastatic Renal Cell Cancer : Working Toward Individual Treatment : Overview for Sorafenib
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-02-20
著者
関連論文
- PD2-2 The Role of Molecular Targeting Therapy for Metastatic Renal Cell Cancer : Working Toward Individual Treatment : Overview for Sorafenib
- A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma